Urogynecology · Menopause
Pelvic floor in menopause: incontinence, prolapse, and pain
The pelvic floor loses collagen, blood supply, and neural coordination during menopause. Leakage, prolapse, and pain rise sharply — and the standard advice ('do Kegels') is wrong for a substantial fraction of women who have hypertonic (too-tight) pelvic floors, not weak ones. Diagnosis first, treatment second.
The three big issues
- Stress incontinence — leakage with cough, sneeze, jump
- Urge incontinence — sudden strong need to void, sometimes with leakage
- Prolapse — pressure, bulging, or "falling out" sensation
Treatment stack
- Vaginal estrogen (2–3× weekly) — foundational for all urogenital issues
- Pelvic floor physical therapy — diagnostic and therapeutic
- Pessary — non-surgical prolapse management
- Surgical repair for advanced prolapse
- Anticholinergics or beta-3 agonists (Myrbetriq) for urge incontinence
What Kindr does
We prescribe vaginal estrogen and refer to pelvic floor PT and urogynecology. Same-week appointments, all 50 states.
Frequently asked questions
Why does incontinence worsen in menopause?
Estrogen supports urethral tissue thickness, blood flow, and collagen. When estrogen drops, the urethra thins and the closure mechanism weakens.
Do Kegels always help?
No. Kegels help stress incontinence from weak pelvic floor. They worsen symptoms in women with hypertonic pelvic floor. See a pelvic floor PT for diagnosis first.
Does HRT help incontinence?
Vaginal estrogen improves urge incontinence, urgency, and recurrent UTIs. Systemic HRT alone has mixed effects on stress incontinence.
What about prolapse?
Estrogen supports vaginal tissue but does not reverse structural prolapse. Pessary, pelvic floor PT, or surgical repair are the primary options.
When should I see a specialist?
Persistent leakage, pain with intercourse, or the feeling of "something falling out" warrants urogynecology or pelvic floor PT referral.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.